[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:leptomeningeal-disease":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":48,"states":49},"Leptomeningeal Disease",6,4,[8,16,22,28,34,42],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT02422641","Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis",[12],"Phase 2","RECRUITING","2026-08-26T02:15:31.806698Z","2026-04-29T02:57:57.155900Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT06548776","Establishing Daily Applicable Parameters for Using Magnetic Resonance Spectroscopy of Spinal Cord",[],"2026-08-26T02:18:42.501841Z","2026-05-05T02:43:27.801313Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT07415018","Optimizing Contrast Dose and Scanning Parameters for Detection of Leptomeningeal Disease",[],"2026-08-26T02:16:04.914942Z","2026-05-05T02:43:27.069048Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":32,"content_modified":33},"NCT07694986","Trial of Therapies With IT cDC1s Combined w\u002F IT Trastuzamab for Her+ or IT Nivolumab for Her- BC LMD",[12],"2026-08-26T02:18:26.932189Z","2026-07-19T19:36:05.174171Z",{"nct_id":35,"title":36,"phases":37,"status":39,"updated_at":40,"content_modified":41},"NCT05809752","A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV)",[38],"Phase 1","ACTIVE_NOT_RECRUITING","2026-08-03T02:16:24.793466Z","2026-05-05T02:43:29.337823Z",{"nct_id":43,"title":44,"phases":45,"status":39,"updated_at":46,"content_modified":47},"NCT03423628","A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer",[38],"2026-08-03T03:23:54.120018Z","2026-05-05T02:43:27.393819Z",[],[]]